Drug Shortage Report for SANDOZ RANITIDINE
Report ID | 93419 |
Drug Identification Number | 02243229 |
Brand name | SANDOZ RANITIDINE |
Common or Proper name | RANITIDINE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RANITIDINE |
Strength(s) | 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2019-09-02 |
Estimated end date | Unknown |
Actual end date | 2021-03-01 |
Shortage status | Resolved |
Updated date | 2023-11-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-11-17 | French | Compare |
v5 | 2023-11-17 | English | Compare |
v4 | 2019-10-15 | French | Compare |
v3 | 2019-10-15 | English | Compare |
v2 | 2019-09-10 | French | Compare |
v1 | 2019-09-10 | English | Compare |
Showing 1 to 6 of 6